Clinical Trials Update: Oct 24, 2002
Depression (Major/Severe) Bipolar Disorders Cancer/Chemotherapy
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch.
This study is to determine if duloxetine is effective when compared to placebo in preventing recurrence of major depressive disorder in patients who have responded to open-label duloxetine treatment. Research sites located throughout the United States.
This research study will compare the safety and efficacy of two active study medications for the treament of bipolar I disorder. Research sites located throughout the United States.
This is a study of a marketed, FDA-approved drug for cancer patients receiving chemotherapy whose red blood cell counts have been getting lower. Research sites located in Kentucky and Maryland.
Copyright 2002 Centerwatch. All rights reserved.